Much of the research and studies make for grim reading with the implications for people and health care systems severe. All the more important to seek allies who can share and add force to your advocacy in order to seek improvements to prevention, encourage early diagnosis, and the best treatments.
New study by Australian researchers investigates how exposure to certain triggers can increase the risk of type 1 diabetes
https://medicalxpress.com/news/2019-05-exposure-triggers-diabetes.html
An update from the Association of British Clinical Diabetologists (ABCD) that aims to mitigate a risk of higher incidence of diabetic ketoacidosis (DKA) without significant hyperglycaemia and other potential complications in people taking SGLT-2 inhibitors.
TIANJIN, June 5 (Xinhua) — Chinese researchers have achieved a breakthrough in developing a new type of hydrogel material for type 1 diabetes mellitus (T1DM) treatment, according to a research team from Tianjin University.
http://www.xinhuanet.com/english/2019-06/05/c_138118775.htm
New findings from a Sweden-based population study found similar cardiovascular disease prevalence and risk rates among both type 1 diabetes (T1D) and type 2 diabetes (T2D) patients.
https://www.mdmag.com/conference-coverage/ada-2019/cardiovascular-event-risks-type-1-2-diabetes
Three Ways Tech is Arming the Battle Against Diabetes
Tech platform chosen by UK NHS to help tackle type 2 diabetes.
https://www.med-technews.com/news/healthtech-firm-s-platform-to-tackle-type-2-diabetes-selecte
Dexcom upgrade available.